NLRP3 and myocardial infarction: BP pre‐treatment in hosts has also been shown to inhibit MI‐induced cardiac fibrosis through a ROS/NLRP3‐dependent mechanism, suggesting that strategies to inhibit the ROS/NLRP3 pathway may lead to novel and efficacious treatments for MI.